Recommended Intervals for Diabetes and Kidney Health Screening in the UK
Regular testing for blood glucose, HbA1c, kidney function markers, and urine albumin is a practical strategy for detecting metabolic and renal health changes before they progress.
Diabetes and kidney disease share a significant clinical connection. An estimated 40% of people with diabetes may develop some form of diabetic kidney disease over time, making combined monitoring a cornerstone of preventive care. Identifying changes to blood sugar regulation and kidney function early can support better management strategies and long-term health outcomes.
The Diabetes and Kidney Health Connection
Raised blood glucose over time can gradually affect the delicate filtering structures within the kidneys. Similarly, kidney impairment can influence how the body regulates glucose and responds to metabolic demands. This bidirectional relationship means screening for both conditions simultaneously can provide a more complete health picture.
- Persistent high blood glucose may damage kidney filtration membranes
- Early kidney changes can be detected before symptoms appear
- Timely intervention may slow the progression of both conditions
Practical Insight: Regular combined screening can help identify metabolic and renal health changes at a stage when lifestyle or clinical interventions may have the most benefit.
Key Biomarkers Assessed in Screening
Blood Glucose and HbA1c Testing
These core markers provide complementary views of glucose metabolism:
- Fasting glucose: A snapshot of blood sugar at a single point in time (after 8–12 hours fasting)
- HbA1c: An average of blood glucose control over the preceding 2–3 months
To understand these markers in depth, see our guide on HbA1c and fasting glucose screening for diabetes and pre-diabetes in the UK.
HbA1c Reference Ranges
| HbA1c Level | Interpretation | Suggested Action |
|---|---|---|
| Below 42 mmol/mol | Normal range | Continue routine screening intervals |
| 42–47 mmol/mol | Prediabetes range | Review lifestyle, increase frequency |
| 48 mmol/mol or above | Consistent with possible diabetes range (requires clinical confirmation) | Seek clinical evaluation promptly — a second confirmatory test is required before a diagnosis can be made |
Kidney Function Markers
These tests assess how effectively the kidneys are filtering and processing waste:
- Serum creatinine and eGFR: Estimated glomerular filtration rate calculated from creatinine levels and age, measuring kidney filtering capacity
- Urine microalbumin: Measures albumin (protein) leakage in urine, an early sign of kidney stress; the basis for the albumin-to-creatinine ratio (ACR) calculation used clinically to assess kidney filtration health
Our detailed overview of interpreting kidney function tests including eGFR, creatinine, and urea covers how these values are evaluated in clinical practice.
eGFR Reference Ranges
| eGFR (mL/min/1.73m²) | Classification | Monitoring Recommendation |
|---|---|---|
| Above 90 | Normal kidney function | Standard risk-based intervals |
| 60–89 | Mildly decreased | Annual monitoring recommended |
| Below 60 | Chronic kidney disease range | Clinical review required |
Urine ACR Reference Ranges
| ACR (mg/mmol) | Classification |
|---|---|
| Below 3 | Normal albumin excretion |
| 3–30 | Microalbuminuria (mildly elevated) |
| Above 30 | Proteinuria (significantly elevated) |
Screening Frequency by Risk Category
Recommended testing intervals vary depending on an individual’s risk profile. The following table provides a general guide based on risk stratification.
| Risk Category | Age Group | HbA1c Interval | Kidney Function Interval |
|---|---|---|---|
| Low risk | 40–49 | Every 3 years | Every 3 years |
| Low risk | 50–64 | Every 2 years | Every 2 years |
| Low risk | 65+ | Annually | Annually |
| Moderate risk | All ages | Annually | Annually |
| High risk | All ages | Every 3–6 months | Every 3–6 months |
Practical Insight: These intervals are general guidance. Individual healthcare providers may recommend different frequencies based on your full clinical picture, medications, and personal health history.
Who Should Consider Regular Screening?
Primary Risk Factors
The following factors may indicate a greater potential benefit from regular diabetes and kidney screening:
- Family history of diabetes or kidney disease
- Age over 40 years
- Overweight or obesity
- Hypertension or cardiovascular disease history
- Previous gestational diabetes
- Polycystic ovary syndrome (PCOS)
- South Asian, Black African, or Black Caribbean ethnicity (increased genetic predisposition)
Family history can span multiple health domains — conditions such as PCOS, hormonal disorders, and metabolic syndrome often cluster together. Our guide on family history and sexual health screening explores how hereditary patterns across these related areas can shape a more complete screening strategy.
NHS and Private Screening Options
NHS Health Checks
The NHS Health Check programme offers eligible adults in England aged 40–74 a health review every 5 years. This can include:
- Blood pressure measurement
- Cholesterol testing
- Blood glucose assessment
- BMI and lifestyle review
Private Screening in London
Private screening can provide more comprehensive testing panels, shorter waiting times, and more frequent screening intervals for those with elevated risk factors. Our dedicated Diabetes & Kidney Health Screening package covers the core metabolic markers — glucose, HbA1c, and urine microalbumin — in a single appointment. Comprehensive kidney function including eGFR and serum creatinine is available as part of our Full Body MOT packages. For a full overview of what the dedicated package includes, see our review of the diabetes and kidney health screening package.
Preparing for Diabetes and Kidney Screening
Pre-Test Preparation
To ensure accurate results, preparation typically involves:
- Fasting for 8–12 hours before blood glucose testing (water is permitted)
- Continuing regular prescribed medications unless a clinician advises otherwise
- Avoiding strenuous exercise in the 24 hours prior to kidney function testing
- Collecting an early morning urine sample if urine ACR is requested
Frequently Asked Questions
How often should I have diabetes screening if I have no symptoms?
For low-risk adults aged 40–49, screening every 3 years may be appropriate. Those with one or more risk factors or aged over 50 may benefit from annual testing. Individual recommendations should come from a healthcare professional.
Is HbA1c or fasting glucose better for diabetes screening?
Both tests provide useful information. HbA1c reflects long-term glucose control (2–3 months), while fasting glucose gives an immediate reading. Many comprehensive screening panels include both markers together.
Can I have kidney function testing through a private clinic without a GP referral?
Yes. Many private clinics in London offer direct access to kidney function panels including eGFR, creatinine, and urine ACR without a GP referral.
What is a normal eGFR result for adults in the UK?
An eGFR above 90 mL/min/1.73m² is generally considered normal. Values between 60–89 indicate mildly decreased kidney function and may warrant monitoring. Results below 60 suggest chronic kidney disease and require clinical evaluation. See our overview of why early detection of kidney disease through eGFR testing is vital.
Does the NHS Health Check include diabetes and kidney testing?
NHS Health Checks for eligible adults aged 40–74 typically include blood glucose assessment and may include some kidney function markers. Private clinics can offer more detailed testing panels with a broader range of biomarkers.
Medical Disclaimer
This article is for educational purposes only and does not constitute medical advice, diagnosis, or treatment recommendations. Screening intervals and reference ranges are general guidance only; individual screening frequency should be determined by a qualified healthcare professional. If you have symptoms or risk factors related to diabetes or kidney disease, please seek professional medical evaluation promptly.
Written Date: 2nd June 2026 | Next Review Date: 2nd June 2027